Type 1 diabetes | Control | p | |
---|---|---|---|
N | 150 | 50 | |
Age (years) | 38.6 ± 8.1 | 38.1 ± 7.2 | NS |
Sex (male/female %) | 58/42 | 56/44 | NS |
Evolution type 1 diabetes (years) | 20.4 ± 8.1 | – | – |
Family history CHD (%) | 20 | 22 | NS |
Body mass index (kg/m2) | 25.1 ± 3.6 | 25.3 ± 4.3 | NS |
Systolic blood pressure (mmHg) | 117.3 ± 13.5 | – | – |
Diastolic blood pressure (mmHg) | 70.9 ± 7.7 | – | – |
Retinopathy (%) | 26 | – | – |
Nephropathy (%) | 9 | – | – |
HbA1c (%, mmol/mol) | 8.1 ± 2.3 (64.9 ± 11.4) | – | – |
Total cholesterol (mg/dl) | 182.7 ± 25.1 | 191.1 ± 34.1 | NS |
HDL (mg/dl) | 60.3 ± 15.1 | 61.8 ± 16.6 | NS |
LDL (mg/dl) | 105.3 ± 21.9 | 111.3 ± 33.5 | NS |
Smoke (% yes/no) | 48/52 | 42/58 | NS |
Statins (%) | 21 | – | – |
Antihypertensive (%) | 15 | – | – |
Acetylsalicylic acid (%) | 16 | – | – |
YKL-40 (ng/ml) | 42.6 (10.4–195.0) | 28.7 (11.0–51.2) | 0.001 |
Adiponectin (mg/ml) | 15.4 ± 8.4 | 11.9 ± 5.1 | 0.007 |
TNF-α (pg/ml) | 7.5 ± 2.4 | 7.8 ± 1.8 | NS |
IL-1β (pg/ml) | 1.0 ± 1.1 | 1.1 ± 0.8 | NS |
IL-6 (pg/ml) | 2.0 ± 9.5 | 3.0 ± 4.0 | NS |
Homocysteine (mmol/l) | 9.74 ± 5.1 | 10.9 ± 3.4 | NS |
hsCRP (mg/l) | 2.21 ± 3,9 | 2.5 ± 3.9 | NS |